Abstract
Two “in vivo” models of inflammation have been used to investigate the role of phospholipases A2 (PLA2) in inflammation. These models are caseininduced peritonitis in the rat and zymosan-induced peritonitis in the mouse. The extracellular PLA2 activities from peritoneal lavage fluid in these two models are similar: they are calcium dependent and have broad neutral pH optima. However, the relationship between extracellular PLA2 activity and cell influx in these models are not identical. In zymosan peritonitis, PLA2 activity preceeded peak cell influx, reaching a maximum within 15 min after zymosan injection, while cell influx peaked by 8 hr. In casein-induced peritonitis, the PLA2 activity peaked at 24 hr, while cell influx continued through 48 hr. The origins of the PLA2 activities in both models remain unclear; one potential source is the plasma. Understanding the role of extracellular PLA2 activity in “in vivo” models, and investigating specific inhibitors in these models may aid in our understanding of the role of extracellular PLA2 in diseases such as rheumatoid arthritis, endotoxin shock and pancreatitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
K. Horigome, M. Hayakawa, K. Inoue, and S. Nojima, Selective release of phospholipase A2 and lysophosphatidylserine specific lysophospholipase from rat platelets, J. Biochem. 101:53 (1987).
M.D. Lister, K.B. Glaser, R.J. Ulevitch, and E.A. Dennis, Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosandienoic acid and p-bromophenacyl bromide, J. Biol. Chem. 264:8520 (1989).
M.D. Lister, R.A. Deems, V. Watanabe, R.J. Ulevitch, and E.A. Dennis, Kinetic analysis of the Ca+2 -dependent, membrane-bound, macrophage phospholipase A2 and the effects of arachidonic acid, J. Biol. Chem. 263:7506 (1988).
P. Vadas, W. Pruzanski, J. Kim, and V. Fornasier, The proinflammatory effect of intraarticular injection of soluble human and venom phospholipase A2, Am. J. Path. 134:807 (1989).
B.S. Vishwanath, A.A. Fawzy, and R.C. Franson, Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid, Inflammation. 12:549 (1988).
W. Pruzanski, E.C. Keystone, B. Sternby, C. Bombardier, K.M. Snow, and P. Vadas, Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis, J. Rheumatol. 15:1351 (1988).
T.J. Nevalainen, The role of phospholipase A2 in acute pancreatitis, Scand. J. Gastroenterol. 15:641 (1980).
P. Vadas and W. Pruzanski, Role of extracellular phopholipase A2 in inflammation, Adv. Infl. Res. 7:51 (1983).
H.W. Chang, I. Kudo, S. Hara, K. Karasawa and K. Inoue, Extracellular phospholipase A2 activity in peritoneal cavity of casein-treated rats, J. Biochem. 100:1099 (1986).
H.W. Chang, I. Kudo, M. Tomita, and K. Inoue, Purification and characterization of extracellular phospholipase A2 from peritoneal cavity of caseinate-treated rat, J. Biochem. 102:147 (1987).
T.M. Stevens, M. McGowan, J. Giannaras and J.S. Kerr, Characterization of extracellular phospholipase A2 activity in fluid and peritoneal cells from casein-treated rats, Inflammation (in press).
N.S. Doherty, P. Poubelle, P. Borgeat, T.H. Beaver, G.L. Westrich and N.L. Schrader, Intraperitoneal injection zymosan in mice induced pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2, Prostaglandins 30:769 (1985).
K.R. Gans, S.R. Lundy, R.L. Dowling, T.M. Stevens and J.S. Kerr, Extracellular phospholipase A2 activity in cell free peritoneal lavage fluid from mice with zymosan peritonitis, Agents Actions 27:341 (1989).
S.R. Lundy, R.L. Dowling, T.M. Stevens, J.S. Kerr, W.M. Mackin and K.R. Gans, Kinetics of phospholipase A2, arachidonic acid and eicosanoid appearance in mouse zymosan peritonitis, J. Immunology (in press).
W. Pruzanski, P. Vadas, E. Stefanski, and M.B. Urowitz, Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme, J. Rheumatol. 12:211 (1985).
P. Vadas and J.B. Hay, The appearance and significance of phospholipase A2 in lymph draining tuberculin reactions, Am. J. Pathol. 107:285 (1982).
R. Franson, C. Dobrow, J. Weiss, P. Elsbach, and W.B. Weglicki, Isolation and characterization of a phospholipase A2 from an inflammatory exudate, J. Lipid Res. 19:18 (1978).
M. Waite. Phospholipase A2 of mammalian cells. In: “Handbook of Lipid Research,” Vol. 5, The Phospholipases. D.J. Hanahan, ed. Plenum Press, New York (1987).
S. Hara, I. Kudo, K. Matsuta, T. Miyamoto, and K. Inoue, Amino acid composition and NH2-terminal amino acid sequence of human phospholipase A2 purified from rheumatoid synovial fluid, J Biochem. 104:326 (1988).
M. Hayakawa, I. Kudo, M. Tomita, and K. Inoue, Purification and characterization of membrane-bound phospholipases A2 from rat platelets, J. Biochem 103:263 (1988).
S. Hara, I. Kudo, H.W. Chang, K. Matsuta, T. Miyamoto and K. Inoue, Purification and characterization of extracellular phospholipase A2 from human synovial fluid in rheumatoid arthritis, J. Biochem. 105:395 (1989).
P. Patriarca, S. Beckerdite, and P. Elsbach, Phospholipases and phospholipid turnover in Escherichia coli spheroplasts, Biochem. Biophys. Acta. 260:593 (1972).
F.F. Davidson, E.A. Dennis, M. Powell, and J.R. Glenney, Inhibition of phospholipase A2 by “lipocortins” and calpactin. An effect of binding to substrate phospholipids, J. Biol. Chem. 262:1698 (1987).
E.G. Bligh and W.J. Dyer, A rapid method of total lipid extraction and purification, Can. J. Biochem Physiol. 37:911 (1959).
G.R. Bartlett. Phosphorus assay in column chromatography, J. Biol. Chem. 234:466 (1959).
R. Franson, P. Patriarca, and P. Elsbach, Phospholipid metabolism by phagocytic cells. Phospholipase A2 associated with rabbit polymorphonuclear leukocyte granules, J. Lipid Res. 15:380 (1974).
W.M. Mackin, S.M. Rakich, and C.L. Marshall, Inhibition of rat neutrophil functional responses by azapropazone, an anti-gout drug, Biochem. Pharmacol. 35:917 (1986).
A.A. Fawzy, R. Dobrow, and R.C. Franson, Modulation of phospholipase A2 activity in human synovial fluid by cations, Inf1ammation 11:389 (1987).
B. Rothhut, F. Russo-Marie, J. Wood, M. DiRosa, and R.J. Flower, Further characterization of the glucocorticoid-induced antiphospholipase protein “renocortin,” Biochem. Biophvs. Res. Comm. 117:878 (1983).
M.M. Bradford. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72:248 (1976).
G.W. Snedecor. Sampling from normally distributed population. In: Statistical Methods, 5th ed., B.W. Snedecor and W.C. Cochran, eds. Iowa State Univ. Press Ames P. 45 (1964).
K. Burton, A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid, Biochem J. 62:315 (1956).
K.W. Giles and A. Meyers, An improved dephenylaaine method for the estimation of deoxyribonucleic acid, Nature 206:93 (1965).
S. Forst, J. Weiss, P. Elsbach, J.M. Maraganore, I. Reardon, and R.L. Heinrikson, Structural and functional properties of a phospholipase A2 purified from an inflammatory exudate, Biochemistry 25:8381 (1986).
S. Forst, J. Weiss, and P. Elsbach, Properties of an inflammatory exudate phospholipase A2 that degrades the phospholipids of E.coli during phagocytosis, Clin. Res. 34:724A (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Gans, K.R., Lundy, S.R., Dowling, R.L., Mackin, W.M., Stevens, T.M., Kerr, J.S. (1990). Extracellular Phospholipase A2 Activity in Two in Vivo Models of Inflammation. In: Wong, P.YK., Dennis, E.A. (eds) Phospholipase A2 . Advances in Experimental Medicine and Biology, vol 275. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5805-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5805-3_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5807-7
Online ISBN: 978-1-4684-5805-3
eBook Packages: Springer Book Archive